Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (101-110 of 362) with videos related to

Pageof 37
Sort By:
Revue Medicale Suisse|May 29, 2020
[Small-cell lung cancer: management and novelties]Karim Abdelhamid, Artemisia Kakourou, Nils Degrauwe, et al.
Swiss Medical Weekly|December 5, 2015
Patients' understanding of blood tests and attitudes to HIV screening in the emergency department of a Swiss teaching hospital: a cross-sectional observational studyTimothée Favre-Bulle, Dimitri Baudat, Katharine E A Darling, et al.
Plos One|August 8, 2022
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitorsDerrek P Hibar, George D Demetri, Solange Peters, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 23, 2024
Beyond Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer: New Frontiers, New ChallengesGiannis Mountzios, Jarushka Naidoo, Chao Wang, et al.
Journal for Immunotherapy of Cancer|December 4, 2019
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patientVincent Pillonel, Vincent Dunet, Andreas F Hottinger, et al.
Journal for Immunotherapy of Cancer|October 26, 2022
First communication on the efficacy of combined <sup>177</sup>Lutetium-PSMA with immunotherapy outside prostate cancerAntonia Digklia, Sarah Boughdad, Krisztian Homicsko, et al.
Melanoma Research|May 15, 2008
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patientsVerena Voelter, Ann Schalenbourg, Sandro Pampallona, et al.
Frontiers in Oncology|January 28, 2026
Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancerSandip Pravin Patel, Justin Gainor, Steven Kao, et al.
The Lancet. Oncology|November 7, 2024
Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer typesKarl Semaan, Rashad Nawfal, Elizabeth Nally, et al.
JAMA Oncology|May 11, 2023
Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations: A ReviewAntonio Passaro, Tony S K Mok, Ilaria Attili, et al.
Pageof 37

Showing results (101-110 of 362) with videos related to

Sort By:
Pageof 37
Revue Medicale Suisse|May 29, 2020
[Small-cell lung cancer: management and novelties]Karim Abdelhamid, Artemisia Kakourou, Nils Degrauwe, et al.
Swiss Medical Weekly|December 5, 2015
Patients' understanding of blood tests and attitudes to HIV screening in the emergency department of a Swiss teaching hospital: a cross-sectional observational studyTimothée Favre-Bulle, Dimitri Baudat, Katharine E A Darling, et al.
Plos One|August 8, 2022
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitorsDerrek P Hibar, George D Demetri, Solange Peters, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 23, 2024
Beyond Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer: New Frontiers, New ChallengesGiannis Mountzios, Jarushka Naidoo, Chao Wang, et al.
Journal for Immunotherapy of Cancer|December 4, 2019
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patientVincent Pillonel, Vincent Dunet, Andreas F Hottinger, et al.
Journal for Immunotherapy of Cancer|October 26, 2022
First communication on the efficacy of combined <sup>177</sup>Lutetium-PSMA with immunotherapy outside prostate cancerAntonia Digklia, Sarah Boughdad, Krisztian Homicsko, et al.
Melanoma Research|May 15, 2008
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patientsVerena Voelter, Ann Schalenbourg, Sandro Pampallona, et al.
Frontiers in Oncology|January 28, 2026
Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancerSandip Pravin Patel, Justin Gainor, Steven Kao, et al.
The Lancet. Oncology|November 7, 2024
Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer typesKarl Semaan, Rashad Nawfal, Elizabeth Nally, et al.
JAMA Oncology|May 11, 2023
Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations: A ReviewAntonio Passaro, Tony S K Mok, Ilaria Attili, et al.
Pageof 37